and Purple Heart.
About Cellphire
Cellphire, Inc., a biotechnology company, is focused on developing stabilized cellular materials for advanced technologies in the therapeutic and diagnostic markets. Current efforts and product development are aimed toward stabilized platelets for advanced wound care, transfusion, and reagent products for clinical and research diagnostics.
For more information please visit: http://www.cellphire.com/.
'/>"/>SOURCE Cellphire, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus2.
Former EPA official calls for new environmental and consumer protection agency3.
Cliff Consulting, Inc. Adds Former Banking IT Executive Ashok Moorthy to Its Team4.
Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences5.
Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR76.
Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member7.
Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise8.
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors9.
Former SADMERC Medical Directors Join OrthoCare Innovations as Medical and Scientific Advisory Board Members and Strategic Advisors10.
Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts11.
Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America